Mutator phenotype may be required for multistage carcinogenesis.
about
Animal cell differentiation patterns suppress somatic evolutionModeling somatic evolution in tumorigenesisThe human G2 checkpoint control protein hRAD9 is a nuclear phosphoprotein that forms complexes with hRAD1 and hHUS1Mechanisms of change in gene copy numberDisruption of Brca2 increases the spontaneous mutation rate in vivo: synergism with ionizing radiation.DNA sequence analysis of spontaneous mutagenesis in Saccharomyces cerevisiaeSpontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPaseDevelopment of a cancer DNA phenotype prior to tumor formationModulation of mismatch repair and genomic stability by miR-155Unbalanced replication as a major source of genetic instability in cancer cellsThe fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerasesIL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cellsOverexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugsGenetic instability of cancer cells is proportional to their degree of aneuploidyChromatid cohesion defects may underlie chromosome instability in human colorectal cancersGenetic reconstruction of individual colorectal tumor historiesIntrauterine environment, mammary gland mass and breast cancer riskThe molecular basis of lung cancer: molecular abnormalities and therapeutic implicationsGenetics and immunity in the era of single-cell genomicsTissue Regeneration in the Chronically Inflamed Tumor Environment: Implications for Cell Fusion Driven Tumor Progression and Therapy Resistant Tumor Hybrid CellsEarly events during neoplastic progression in Barrett's esophagusNon-targeted effects of ionising radiation--implications for low dose risk.Single-molecule views of MutS on mismatched DNA.The c-Myc target glycoprotein1balpha links cytokinesis failure to oncogenic signal transduction pathways in cultured human cellsA genetic screen for increased loss of heterozygosity in Saccharomyces cerevisiae.Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damageRepair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cellsLoss of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in gastric cancersInduction of microsatellite instability by oxidative DNA damageEpigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcomeThe future role of personalized medicine in the treatment of glioblastoma multiformeStepwise deletions of polyA sequences in mismatch repair-deficient colorectal cancersCancer missense mutations alter binding properties of proteins and their interaction networksDNA repair deficiency as a susceptibility marker for spontaneous lymphoma in golden retriever dogs: a case-control studyDifferent mutator phenotypes in Mlh1- versus Pms2-deficient miceSolutions to Peto's paradox revealed by mathematical modelling and cross-species cancer gene analysisThe rate of spontaneous mutations in human myeloid cellsMutation rate dynamics in a bacterial population reflect tension between adaptation and genetic loadColorectal adenoma and cancer divergence. Evidence of multilineage progressionEvolution of BCR/ABL gene mutation in CML is time dependent and dependent on the pressure exerted by tyrosine kinase inhibitor.
P2860
Q21145656-3F498A4F-EC79-4C57-B66E-6453085E4D44Q21563511-AD2D3B6B-C877-4DC3-A8CC-A7F9BB574634Q22009947-65300503-7481-46F9-B338-178A2119730FQ22122003-B8809D4F-3EA0-4F61-AAFD-B6029F7AB873Q22242910-C62DB296-2E14-4FCD-AE4D-EF18B5A07750Q24548004-9B167539-D61C-48B1-B5F3-175399998926Q24555183-B69F0CB9-4E51-46E4-AC0E-CF76BEC52485Q24561951-415A4BB1-28BD-41F4-B816-234487F64062Q24612859-0DFC7860-8025-4E54-8218-6F07A65ACE02Q24621737-3D466816-A4FF-40FB-8302-7F0710340E10Q24630867-29583D37-6623-4A25-A0F5-AEA3ED8080CBQ24634798-4C1DFD95-5786-42EA-A247-FEBFE0EC113EQ24644933-7C135DE8-B117-4E40-805F-75308DDCE8EAQ24653805-8C903916-8DE7-44F5-AC9D-4D790276D11BQ24656162-93B738FE-7355-4B35-8AF5-E4F67139561AQ24670186-FDA764FE-83CE-4E21-867D-937A034B5D75Q24795107-AE1752C1-9ACF-4C1F-9EE6-73995DCEBAABQ24802445-CD1C9DE8-808F-40F3-BE45-8F4E69229EF0Q26740484-5DF6BCAA-4499-4AAA-8877-211F3A426973Q26772032-67A597F0-FC33-41A9-BB79-24E4508EA07BQ26825349-B90C174F-93F1-492F-B2EF-7ECE5780C6CFQ26825698-641DDA19-34EB-403E-8176-9D4CC77A90A3Q26999680-8DA5C1A3-495D-41F1-903D-B50410D3EB81Q27327190-0F9A8BCD-1483-4EF7-9B37-5757B035AF3CQ27933133-443E7B9B-C5EA-484A-B2F6-CE4EE952D3DAQ28114912-CC592181-8FCB-46C8-804B-1CDF805FBCE1Q28209896-1E0B4A7C-FDF2-4611-9187-F6AB634E097AQ28266411-DD12DE6B-F55F-4697-A962-30F0AD955362Q28285253-335B208D-619B-4593-8119-6D0F4AA4AE67Q28391055-732D642C-45EB-4131-9D95-178601751CA7Q28391635-5E889757-4CC6-4534-90E9-3EEAB6AD3A09Q28507252-E3B727B2-E085-4B03-A3EB-514FA42D5F74Q28533927-53D33C8B-D7A9-4822-A232-940D91EC7502Q28534784-7CFCAABB-B174-4685-86DF-2E33F2FB8FB6Q28592891-29E96F95-E7C2-4EFF-9151-8710A5D5D31AQ28607306-A0716458-29AF-443C-8AF2-04BCFD61C274Q28645706-8B39660A-04AA-436D-B343-C99542898226Q28710085-859B777C-A2E4-4F51-9A8B-F9461DE0A17EQ28755827-EB29CF42-B0C4-467D-9549-4ABDB1AF886EQ30009238-B9D34DB7-26C9-4D1B-B3EE-B6562772A04B
P2860
Mutator phenotype may be required for multistage carcinogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on June 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Mutator phenotype may be required for multistage carcinogenesis.
@en
Mutator phenotype may be required for multistage carcinogenesis.
@nl
type
label
Mutator phenotype may be required for multistage carcinogenesis.
@en
Mutator phenotype may be required for multistage carcinogenesis.
@nl
prefLabel
Mutator phenotype may be required for multistage carcinogenesis.
@en
Mutator phenotype may be required for multistage carcinogenesis.
@nl
P1433
P1476
Mutator phenotype may be required for multistage carcinogenesis.
@en
P2093
P304
P407
P577
1991-06-01T00:00:00Z